Insider Trading History of Anido Armando

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Anido Armando since 2006. This trader's CIK number is 1219866. At the time of last reporting, Anido Armando was the Chairman & Chief Exec. Officer of Zynerba Pharmaceuticals, Inc.. (stock ticker symbol ZYNE). Also see all insider trading activities at Zynerba Pharmaceuticals, Inc..

Note that in the past ANIDO ARMANDO also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Medimmune Inc /de (MEDI) by Anido Armando

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 MEDI 0 $0 11,562 $377,788 11,562 $275,291

Yearly summary of insider trading at Auxilium Pharmaceuticals Inc (AUXL) by Anido Armando

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 AUXL 0 $0 31,660 $670,202 31,660 $247,262
2010 AUXL 0 $0 30,000 $992,129 30,000 $234,300
2009 AUXL 0 $0 60,000 $1,800,870 60,000 $468,600

Yearly summary of insider trading at Adolor Corp (ADLR) by Anido Armando

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 ADLR 0 $0 0 $0 150,000 $304,800

Yearly summary of insider trading at Scynexis Inc (SCYX) by Anido Armando

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 SCYX 5,000 $31,250 0 $0 0 $0

Yearly summary of insider trading at Zynerba Pharmaceuticals, Inc. (ZYNE) by Anido Armando

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 ZYNE 0 $0 53,283 $44,842 0 $0
2022 ZYNE 0 $0 11,899 $13,088 0 $0
2018 ZYNE 15,000 $89,430 0 $0 0 $0
2017 ZYNE 5,000 $98,515 0 $0 0 $0


Insider trading activities at 5 companies by Anido Armando:

1. Medimmune Inc /de (MEDI)

2. Auxilium Pharmaceuticals Inc (AUXL)

3. Adolor Corp (ADLR)

4. Scynexis Inc (SCYX)

5. Zynerba Pharmaceuticals, Inc. (ZYNE)

Table 1. Insider trading of Medimmune Inc /de (MEDI) by Anido Armando

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-02-03 MEDI Option Ex 11,562 23.81 275,291
2006-02-03 MEDI Sale 11,562 32.67 377,788

Table 2. Insider trading of Auxilium Pharmaceuticals Inc (AUXL) by Anido Armando

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-10-07 AUXL Option Ex 5,275 7.81 41,197
2011-10-07 AUXL Sale 5,275 14.23 75,047
2011-07-08 AUXL Option Ex 5,275 7.81 41,197
2011-07-08 AUXL Sale 5,275 20.30 107,103
2011-03-08 AUXL Option Ex 10,555 7.81 82,434
2011-03-08 AUXL Sale 10,555 23.02 242,997
2011-01-10 AUXL Option Ex 10,555 7.81 82,434
2011-01-10 AUXL Sale 10,555 23.22 245,055
2010-04-12 AUXL Option Ex 30,000 7.81 234,300
2010-04-12 AUXL Sale 30,000 33.07 992,129
2009-06-26 AUXL Option Ex 30,000 7.81 234,300
2009-06-26 AUXL Sale 30,000 30.30 908,910
2009-03-16 AUXL Option Ex 30,000 7.81 234,300
2009-03-16 AUXL Sale 30,000 29.73 891,960

Table 3. Insider trading of Adolor Corp (ADLR) by Anido Armando

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-12-07 ADLR Option Ex 150,000 2.03 304,800

Table 4. Insider trading of Scynexis Inc (SCYX) by Anido Armando

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-21 SCYX Buy 5,000 6.25 31,250

Table 5. Insider trading of Zynerba Pharmaceuticals, Inc. (ZYNE) by Anido Armando

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-09-13 ZYNE Sale 17,830 1.33 23,642
2023-01-23 ZYNE Sale 35,453 .60 21,200
2022-07-19 ZYNE Sale 11,899 1.10 13,088
2018-08-06 ZYNE Buy 15,000 5.96 89,430
2017-05-12 ZYNE Buy 3,500 19.76 69,160
2017-05-15 ZYNE Buy 1,500 19.57 29,355

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anido Armando (Chairman & Chief Exec. Officer of Zynerba Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.